RUSSELL FRANK CO/ - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 91 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2014. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.

Quarter-by-quarter ownership
RUSSELL FRANK CO/ ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q4 2015$79,000
+132.4%
27,998
+160.2%
0.00%
Q3 2015$34,000
-64.6%
10,760
-33.3%
0.00%
Q2 2015$96,000
+3100.0%
16,140
+6597.1%
0.00%
Q1 2015$3,000
-99.8%
241
-99.9%
0.00%
-100.0%
Q4 2014$1,768,000
+167.9%
187,672
+118.5%
0.00%
+200.0%
Q3 2014$660,000
-19.3%
85,893
-21.0%
0.00%0.0%
Q2 2014$818,000
+5742.9%
108,749
+2047.9%
0.00%
Q3 2013$14,0005,063
+8941.1%
0.00%
Q2 2013$0560.00%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q2 2014
NameSharesValueWeighting ↓
Aisling Capital LLC 2,010,000$905,0000.21%
GLOBEFLEX CAPITAL L P 226,959$102,0000.03%
ACUTA CAPITAL PARTNERS, LLC 62,800$28,0000.01%
MENTA CAPITAL LLC 195,136$87,0000.01%
Orbimed Advisors 1,073,000$481,0000.01%
GOODWIN DANIEL L 22,679$10,0000.00%
TUDOR INVESTMENT CORP ET AL 215,800$97,0000.00%
Renaissance Technologies 2,214,396$992,0000.00%
STOCK YARDS BANK & TRUST CO 30,170$14,0000.00%
HIGHLAND CAPITAL MANAGEMENT, LLC 41,000$18,0000.00%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders